Engagement of SLAM by an agonist mAb during the allergen-specific expansion of Th2 cell populations derived from the skin biopsies of patients with AD resulted in the generation of stable populations of IFN-γ-producing cells. Here, SLAMF1 is linked to Alzheimer disease.